Sepsis Epidemiology Analysis and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$3995

Sepsis Report Overview

In the 8MM, there were 7,614,342 diagnosed incident cases of sepsis in 2023. The diagnosed incident cases of sepsis will register an AGR of more than 2% during 2023-2033. Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its tissues and organs. Sepsis causes multiple organ failure and death, especially if it is not recognized early and treated promptly. Anyone can develop sepsis, but the condition is more common in children younger than one year of age, older adults, and those with weakened immune systems.

Sepsis Market Outlook, 2023-2033 (Diagnosed incident cases)

Sepsis Market Outlook, 2023-2033 (Diagnosed incident cases)

Buy the Full Report for More Insights into the Sepsis Market Forecast

Download a Free Report Sample

The Sepsis market research report provides an overview of the risk factors and the global and historical epidemiological trends for sepsis and septic shock in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China). Additionally, this report includes a 10-year epidemiological forecast of sepsis for men and women from 2023–33 for the following segmentations in all ages across the 8MM: diagnosed incident cases of sepsis segmented by sex and age (ages 0–28 days, 1 month–17 years, 18–64 years, and 65 years and older).

Market Size (2022) 7,614,342 Cases
AGR (2023-2033) >2%
Forecast Period 2023-2033
Key Countries ·       China

·       The US

·       France

·       Germany

·       Spain

·       Italy

·       The UK

·       Japan

Key Sex Segments ·       Men

·       Women

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Sepsis Market Segmentation by Country

The key countries across the 8MM are the US, France, Germany, Spain, Italy, the UK, and Japan. In 2023, China accounted for the highest percentage of diagnosed incident cases of sepsis in the 8MM. The country is expected to see the largest growth in cases from 2023–33. The increase in the diagnosed incident cases of sepsis is partly attributed to the rising trend in the historic incidence in the 8MM, combined with underlying demographic changes in the respective markets.

`Sepsis Market Analysis by Country, 2023 (%)

`Sepsis Market Analysis by Country, 2023 (%)

Buy the Full Report for More Country Insights into the Sepsis Market
Download a Free Report Sample

Sepsis Market Segmentation by Sex

Based on sex, the market can be segmented into men and women. In 2023, the diagnosed incident cases of sepsis in the 8MM were higher in men than women. The differences in the numbers of diagnosed incident cases of sepsis across the sexes and markets may be mostly attributed to differences in the underlying demographic differences in each market. Also, the significant differences in sex-specific diagnosed incidence.

Sepsis Market Analysis by Sex, 2023 (%)

Sepsis Market Analysis by Sex, 2023 (%)

Buy the Full Report for More Sex Insights into the Sepsis Market

Download a Free Report Sample

Segments Covered in the Report

Sepsis Market Country Outlook (Diagnosed incident cases)

  • China
  • The US
  • France
  • Germany
  • Spain
  • Italy
  • The UK
  • Japan

Sepsis Market Sex Outlook (Diagnosed incident cases)

  • Men
  • Women

Scope

  • This report provides an overview of the risk factors and the global and historical epidemiological trends for sepsis and septic shock in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China).
  • Additionally, this report includes a 10-year epidemiological forecast of sepsis for men and women from 2023–33 for the following segmentations in all ages across the 8MM: diagnosed incident cases of sepsis segmented by sex and age (ages 0–28 days, 1 month–17 years, 18–64 years, and 65 years and older), diagnosed incident cases of sepsis by causative agent (Gram positive and Gram negative bacteria, fungi, and other organism), diagnosed incident cases of sepsis by organ dysfunction (acute kidney dysfunction, acute respiratory dysfunction, disseminated intravascular coagulopathy [DIC], hepatic dysfunction, and cardiovascular dysfunction), and in-hospital mortality of sepsis.
  • This report also includes a 10-year epidemiological forecast of septic shock for men and women from 2023–33 for the following segmentations in all ages across the 8MM: diagnosed incident cases of septic shock segmented by sex and age (0–28 days, 1 month–17 years, 18–64 years, and 65 years and older), diagnosed incident cases of septic shock by causative agent, agent (gram positive and gram negative bacteria, fungi, and other organism) diagnosed incident cases of septic shock by organ dysfunction (acute kidney dysfunction, acute respiratory dysfunction, DIC, hepatic dysfunction, and cardiovascular dysfunction), and in-hospital mortality of septic shock.

Reasons to Buy

Sepsis Epidemiology series will allow you to:

  • Develop business strategies by understanding the trends shaping and driving the global sepsis markets.
  • Quantify patient populations in the global sepsis markets to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis therapeutics in each of the markets covered.
  • Understand magnitude of the sepsis population by age, sex, causative agent, and organ dysfunction.

Table of Contents

  • 1. List of Contents

    • 1.1. List of Tables
    • 1.2. List of Figures

  • 2. About GlobalData
  • 3. Sepsis: Executive Summary

    • 3.1. Catalyst
    • 3.2. Related reports
    • 3.3. Upcoming reports

  • 4. Epidemiology

    • 4.1. Disease background
    • 4.2. Risk factors and comorbidities.
    • 4.3. Global and historical trends
    • 4.4. 8MM forecast methodology.

      • 4.4.1. Sources
      • 4.4.2. Forecast assumptions and methods.
      • 4.4.3. Forecast assumptions and methods: diagnosed incident cases of sepsis
      • 4.4.4. Forecast assumptions and methods: diagnosed incident cases of sepsis by causative agent.
      • 4.4.5. Forecast assumptions and methods: organ dysfunction in diagnosed incident cases of sepsis.
      • 4.4.6. Forecast assumptions and methods: sepsis in-hospital mortality cases.
      • 4.4.7. Forecast assumptions and methods: diagnosed incident cases of septic shock.
      • 4.4.8. Forecast assumptions and methods: diagnosed incident cases of septic shock by causative agent.
      • 4.4.9. Forecast assumption and methods: organ dysfunction in diagnosed incident cases of septic shock.
      • 4.4.10. Forecast assumption and methods: septic shock in-hospital mortality cases.

    • 4.5. Epidemiological forecast for sepsis and septic shock (2023–33)

      • 4.5.1. Diagnosed incident cases of sepsis.
      • 4.5.2. Age-specific diagnosed incident cases of sepsis
      • 4.5.3. Sex-specific diagnosed incident cases of sepsis
      • 4.5.4. Diagnosed incident cases of sepsis by causative agent.
      • 4.5.5. Organ dysfunction in diagnosed incident cases of sepsis
      • 4.5.6. Sepsis in-hospital mortality cases
      • 4.5.7. Diagnosed incident cases of septic shock.
      • 4.5.8. Age-specific diagnosed incident cases of septic shock
      • 4.5.9. Sex-specific diagnosed incident cases of septic shock
      • 4.5.10. Diagnosed incident cases of septic shock by causative agent
      • 4.5.11. Organ dysfunction in diagnosed incident cases of septic shock
      • 4.5.12. Septic shock in-hospital mortality cases

    • 4.6. Discussion

      • 4.6.1. Epidemiological forecast insight
      • 4.6.2. COVID-19 impact.
      • 4.6.3. Limitations of the analysis
      • 4.6.4. Strengths of the analysis

  • 5. Appendix

    • 5.1. Bibliography
    • 5.2. About the Authors

      • 5.2.1. Epidemiologist
      • 5.2.2. Reviewers
      • 5.2.3. Vice President of Disease Intelligence and Epidemiology
      • 5.2.4. Global Head of Pharma Research, Analysis and Competitive Intelligence

  • 6. Contact Us

Table

Table 1: Summary of updated data types

Table 2: Risk factors and comorbidities for sepsis

Figures

Figure 1: 8MM, diagnosed incident cases of sepsis, both sexes, N, all ages, 2023 and 2033

Figure 2: 8MM, diagnosed incident cases of septic shock, both sexes, N, all ages, 2023 and 2033

Figure 3: 8MM, diagnosed incidence of sepsis, all ages, both sexes, cases per 100,000 population, 2013‒33

Figure 4: 8MM, diagnosed incidence of septic shock, all ages, both sexes, cases per 100,000 population, 2013‒33

Figure 5: 8MM, sources used and not used to forecast diagnosed incident cases of sepsis and septic shock

Figure 6: 8MM, sources used to forecast the diagnosed incident cases of neonatal sepsis and septic shock

Figure 7: 8MM, sources used to forecast the diagnosed incident cases of sepsis/septic shock by causative agents

Figure 8: 8MM, sources used to forecast organ dysfunction in the diagnosed incident cases of sepsis

Figure 9: 8MM, sources used to forecast organ dysfunction in the diagnosed incident cases of septic shock

Figure 10: 8MM, sources used for sepsis/septic shock in-hospital mortality cases

Figure 11: 8MM, diagnosed incident cases of sepsis, both sexes, all ages, N, 2023

Figure 12: 8MM, age-specific diagnosed incident cases of sepsis, all ages, N, 2023

Figure 13: 8MM, sex-specific diagnosed incident cases of sepsis, all ages, N, 2023

Figure 14: 8MM, diagnosed incident cases of sepsis by causative agent, both sexes, all ages, N, 2023

Figure 15: 8MM, organ dysfunction in diagnosed incident cases of sepsis, both sexes, all ages, N, 2023

Figure 16: 8MM, sepsis in-hospital mortality cases, both sexes, all ages, N, 2023

Figure 17: 8MM, diagnosed incident cases of septic shock, both sexes, all ages, N, 2023

Figure 18: 8MM, age-specific diagnosed incident cases of septic shock, both sexes, N, 2023

Figure 19: 8MM, sex-specific diagnosed incident cases of septic shock, all ages, N, 2023

Figure 20: 8MM, diagnosed incident cases of septic shock by causative agent, both sexes, all ages, N, 2023

Figure 21: 8MM, organ dysfunction in diagnosed incident cases of septic shock, both sexes, all ages, N, 2023

Figure 22: 8MM, septic shock in-hospital mortality cases, both sexes, all ages, N, 2023

Frequently asked questions

Sepsis Epidemiology Analysis and Forecast to 2033 standard reports
Currency USD
$3,995

Can be used by individual purchaser only

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Sepsis Epidemiology Analysis and Forecast to 2033 in real time.

  • Access a live Sepsis Epidemiology Analysis and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.